Literature DB >> 29110227

Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.

William Paul Skelton1, Hiral Parekh2, Jason S Starr2, Jose Trevino3, Jessica Cioffi3, Steven Hughes3, Thomas J George4.   

Abstract

INTRODUCTION: Pancreatic cancer is often diagnosed at late stages, where disease is either locally advanced unresectable or metastatic. Despite advances, long-term survival is relatively non-existent. DISCUSSION: This review article discusses clinical factors commonly encountered in practice that should be incorporated into the decision-making process to optimize patient outcomes, including performance status, nutrition and cachexia, pain, psychological distress, medical comorbidities, advanced age, and treatment selection.
CONCLUSION: Identification and optimization of these clinical factors could make a meaningful impact on the patient's quality of life.

Entities:  

Keywords:  Cachexia; Nutrition; Pain; Pancreatic cancer; Performance status; Personalized treatment

Mesh:

Year:  2018        PMID: 29110227     DOI: 10.1007/s12029-017-0021-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  88 in total

1.  Interleukin 6 is associated with cachexia in patients with prostate cancer.

Authors:  Kenji Kuroda; Jun Nakashima; Kent Kanao; Eiji Kikuchi; Akira Miyajima; Yutaka Horiguchi; Ken Nakagawa; Mototsugu Oya; Takashi Ohigashi; Masaru Murai
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

Review 2.  Systemic inflammation, cachexia and prognosis in patients with cancer.

Authors:  Christopher Deans; Stephen J Wigmore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-05       Impact factor: 4.294

Review 3.  Celiac plexus block for pancreatic cancer pain in adults.

Authors:  Paolo G Arcidiacono; Giliola Calori; Silvia Carrara; Ewan D McNicol; Pier A Testoni
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

4.  Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma.

Authors:  H M Ceha; G van Tienhoven; D J Gouma; C H Veenhof; C J Schneider; E A Rauws; S S Phoa; D González González
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

5.  Surgical palliation for pancreatic cancer. The UCLA experience.

Authors:  S M Singh; W P Longmire; H A Reber
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

6.  Pancreatic cancer: Patient and caregiver perceptions on diagnosis, psychological impact, and importance of support.

Authors:  Anitra Engebretson; Lynn Matrisian; Cara Thompson
Journal:  Pancreatology       Date:  2015-05-29       Impact factor: 3.996

Review 7.  Road map for pain management in pancreatic cancer: A review.

Authors:  Marie José Lahoud; Hampig Raphael Kourie; Joelle Antoun; Lana El Osta; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  The surgeon's role in the treatment of chronic intestinal pseudoobstruction.

Authors:  M M Murr; M G Sarr; M Camilleri
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.

Authors:  Surendra K Shukla; Teklab Gebregiworgis; Vinee Purohit; Nina V Chaika; Venugopal Gunda; Prakash Radhakrishnan; Kamiya Mehla; Iraklis I Pipinos; Robert Powers; Fang Yu; Pankaj K Singh
Journal:  Cancer Metab       Date:  2014-09-01
View more
  3 in total

1.  Synergistic effect of the herbal mixture C5E on gemcitabine treatment in PANC‑1 cells.

Authors:  Pyo June Pak; Dong Gun Lee; Ji Hyun Sung; Seung Hyun Jung; Tae-Young Han; Sung Hyo Park; Namhyun Chung
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

Review 2.  Determining the factors affecting energy metabolism and energy requirement in cancer patients.

Authors:  Tuğçe Bulmuş Tüccar; Nilüfer Acar Tek
Journal:  J Res Med Sci       Date:  2021-12-22       Impact factor: 1.852

Review 3.  From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer.

Authors:  Andrés Muñoz Martín; Manuel Hidalgo; Rafael Alvarez; Virginia Arrazubi; Joaquina Martínez-Galán; Mercedes Salgado; Teresa Macarulla; Alfredo Carrato
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.